Skip to main content

Day: November 16, 2019

Updated Data from Phase 1 ADP-A2M4 Trial Demonstrating Continued Clinical Benefit for People with Synovial Sarcoma

– Clinical responses in seven out of 14 patients with synovial sarcoma by RECIST 1.1 –– Clinical benefit in 13 out of 14 patients –– One RECIST response maintained for more than 9 months after SPEAR T-cell infusion –PHILADELPHIA and OXFORDSHIRE, United Kingdom, Nov. 16, 2019 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, presented updated data from people with synovial sarcoma treated in the ongoing Phase 1 trial with ADP-A2M4. The oral presentation by Brian Van Tine, MD, PhD of Washington University School of Medicine in St. Louis, took place earlier today at the Connective Tissue Oncology Society (CTOS) annual meeting in Tokyo, Japan. Today’s presentation was an update of the data that Dr. Van Tine presented at ESMO on September 30.Out...

Continue reading

China Gold International Reports Change in Board Composition

VANCOUVER, British Columbia, Nov. 15, 2019 (GLOBE NEWSWIRE) — China Gold International Resources Corp. Ltd. (TSX: CGG; HKEx: 2099) (the “Company” or “China Gold International Resources”) announces that, effective immediately, its board of directors (the “Board”) has accepted the following change in the Board composition.The board of directors of the Company (the “Board”) hereby announces that Mr. SONG Xin (先生) has resigned as the Chairman and Executive Director of the Company with effect from November 14, 2019, Vancouver time. Mr. SONG tendered his resignation in order to assume and devote his time to his new position as Chairman of China Energy Conservation and Environmental Protection Group Co. Ltd.Mr. SONG has confirmed that he has no disagreement with the Board and there are no matters relating to his resignation that need to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.